Date: July 23, 2026
KMP / Board / Auditor Changes
Not Specified
Dividend Declaration or Non-Declaration
Not Specified
Board Meeting Outcomes
Not Specified
Financial Results
Not Specified
Disinvestment / Strategic Actions
Not Specified
Other Operational / Legal / Strategic Disclosures
Business Responsibility and Sustainability Report Details
I. Details of the listed entity
- Year of incorporation: 2000
- Corporate address: 261/A, 2nd floor, Bommasandra Industrial Area, Anekal Taluk, Bangalore – 560099
- Contact: investorrelations@narayanahealth.org, +91-8050009318
- Financial year: 2025-26
- Listed on: BSE Limited and National Stock Exchange of India Limited
- Paid-up Capital: ₹2043.61 million
- BRSR Contact: Mr. Jyotish Kumar, nh.esg@narayanahealth.org, Tel: +91 8527193858
- Reporting boundary: Standalone basis (excludes environmental parameters for Heart Centers in Dharwad and Kolar, and hospital in Davangere)
- Assurance Provider: SGS India Private Ltd.
- Assurance Type: BRSR Core Indicators- Reasonable Assurance and limited Assurance of selected indicators
II. Products and Services
- Hospital and Medical Care (Health Care Services): 94.84% of turnover (NIC Code: 8610)
- Sale of Medical Consumables & Drugs: 3.24% of turnover (NIC Code: 4772)
- Export of Medical Consumables & Drugs: 1.92% of turnover (NIC Code: 4649)
III. Operations
- National locations: 18 owned/operated hospitals, 2 heart centres, 20 clinics and dialysis centers across 11 states
- International locations: 2 hospitals in Cayman Islands, 13 hospitals in United Kingdom
- Export contribution: 1.92% of total turnover
- Customers: Primarily patients seeking healthcare services and medical treatment
IV. Employees
- Total employees: 15,467 (Permanent: 11,234; Other than Permanent: 4,233)
- Gender distribution: Male 42.60% (6,590), Female 57.39% (8,877)
- Differently abled employees: 18 total (Permanent: 15; Other than Permanent: 3)
- Women representation: Board of Directors 30% (3 out of 10), KMP 33% (1 out of 3)
- Turnover rate for permanent employees: FY26 33.11%, FY25 31.11%, FY24 30.48%
V. Holding, subsidiary and associate companies
22 subsidiaries and associates listed, including:
- 10 wholly-owned subsidiaries
- 5 step-down subsidiaries
- 2 associates (Reya Health Inc 43.58%, Everhope Oncology Private Limited 39.00%)
- Majority participate in Business Responsibility initiatives
VI. CSR Details
- CSR applicable: Yes
- Turnover: ₹39,751.41 million
- Net worth: ₹25,991.71 million
VII. Transparency and Disclosure Compliances
- Grievance mechanisms in place for all stakeholder groups
- FY26 complaints: Employees (17), Customers - Regular (3,413), Customers - Litigations (22)
- All complaints resolved except 1 litigation pending from previous year
Material Responsible Business Conduct Issues
10 material issues identified including Health & Safety (Risk), Access to Healthcare (Opportunity), Process Safety & Quality (Risk), Data Security & Privacy (Risk), Energy Efficiency (Opportunity), Water Stress (Risk)
Management and Process Disclosures
- Policies extend to value chain partners: Yes
- Accreditations: JCI Enterprise Accreditation, 18 NABH-accredited units, 14 NABL-accredited laboratories, 17 NABH Nursing Excellence units, 14 ISO 13485 certifications
- ESG Targets: Carbon Neutral by 2040, 50% Renewable Energy by 2030, 100% Waste-Water Recycling by 2030
- FY26 Performance: Renewable Energy mix 39.08% (target 38%), Carbon saved 28,300 tons (target 28,000), Wastewater recycling 95% (target 95%)
Governance, leadership and oversight
- Director statement highlights ESG integration, 39.08% renewable energy achievement, community education programs impacting 33,500+ students
- Stakeholders' Relationship Committee oversees sustainability: Mr. Naveen Tewari (Chairman), Dr. Nachiket Mor, Mr. Viren Prasad Shetty
- Board committee reviews performance against policies annually
Principle-Wise Performance Disclosure
Principle 1: Ethical Conduct
- Training coverage: Board & KMP 100%, Employees 94%
- Zero fines/penalties in proceedings
- Anti-corruption policy in place
- Zero disciplinary actions for bribery/corruption
- Accounts payable days: FY26 100 days, FY25 78 days
- Related party transactions: Purchases 28.34%, Sales 3.16%, Loans & advances 85.52%, Investments 81.31%
Principle 2: Sustainable Goods/Services
- R&D expenditure: ₹60 million allocated to clinical research
- Capex on environmental improvements: 5.14% of total capex
- Sustainable sourcing: 50% of inputs by value
- Waste management procedures in place for all waste types
- EPR not applicable
Principle 3: Employee Well-being
- 100% employees covered under well-being measures
- Well-being spending: 0.48% of total revenue
- Retirement benefits: 100% coverage for PF, Gratuity, Group Insurance; 33% for ESI
- Workplace accessible to differently abled
- Equal opportunity policy in place
- Return to work rate after parental leave: 97%
- Grievance mechanism available for all employees
- Training: 88.29% employees trained on health/safety, 100% on skill upgradation
- Performance reviews: 100% of eligible employees
- Occupational health and safety system implemented covering all operations
- Zero safety incidents, zero fatalities
- Comprehensive safety measures including SOPs, training, mock drills, BCP
Principle 4: Stakeholder Engagement
- Stakeholders identified: Internal (employees, management, shareholders) and External (customers, suppliers, investors, regulators, community)
- Engagement frequency varies from quarterly to need-based
- Community engagement focuses on vulnerable/marginalized groups
Principle 5: Human Rights
- 80.18% employees trained on human rights policies
- 100% employees paid above minimum wage
- Median remuneration: BoD Male ₹45.75L, Female ₹42.75L; KMP Male ₹568.02L, Female ₹350.26L
- Gross wages to females: 46.72% of total wages
- Human rights focal point established
- 13 POSH complaints reported, all upheld
- Human rights requirements in business agreements
- 100% assessment coverage for sexual harassment
Principle 6: Environmental Protection
- Energy consumption: 239,184.94 GJ total, 39.08% from renewable sources
- Energy intensity: 0.67 GJ/₹Lakh, 13.93 GJ/Occupied bed days, 0.07 GJ/Sq. feet
- Water withdrawal: 1,053,382 KL (Groundwater 602,755 KL, Third-party 450,627 KL)
- Water consumption: 762,839 KL
- Water intensity: 37.37 KL/₹Lakh PPP, 1.04 KL/Occupied bed days, 0.25 KL/Sq. feet
- Water discharge: 290,543.59 KL with tertiary treatment
- 4 hospitals with Zero Liquid Discharge systems
- Air emissions: NOx 344.39 kg, SOx 317.57 kg, PM 240.77 kg, VOC 210.24 kg, HAP 28.14 kg
- GHG emissions: Scope 1 21,897.77 tCO2e, Scope 2 26,784.82 tCO2e
- Emission intensity: 0.12 tCO2e/₹Lakh, 2.39 tCO2e/₹Lakh PPP, 0.07 tCO2e/Occupied bed days
- Waste generated: 7,125.30 MT total (Plastic 22.98, E-waste 32.91, Bio-medical 1,763.67, Construction 2,653.31, Battery 7.93, Hazardous 8.85, Non-hazardous 2,635.74)
- Waste recovered: 1,303.94 MT recycled
- Waste disposed: Incineration 637.38 MT, Landfilling 430.07 MT, Other 4,753.90 MT
- Compliant with all environmental laws
- Environmental Clearance obtained for BG Road hospital project
Principle 7: Public Policy
- 4 affiliations with trade/industry associations
- No anti-competitive conduct cases
- Public policy advocacy in medical education reforms, healthcare technology guidelines, health sector reforms
Principle 8: Inclusive Development
- No Social Impact Assessments required
- No Rehabilitation and Resettlement projects
- Community grievance mechanism through CSR policy
- 15.25% input material sourced from MSMEs/small producers
- 97.35% input material sourced from within India
- Job creation: Semi-urban 3.32%, Urban 18.38%, Metropolitan 78.29%
Principle 9: Consumer Responsibility
- Grievance redressal mechanism through multiple channels
- No product recalls required
- Cyber security and data privacy policy in place
- Zero data breaches
- Customer satisfaction surveys conducted with 4.8/5 Google rating and 76% NPS
Assurance
- Independent assurance by SGS India Private Limited
- Reasonable assurance on BRSR Core indicators
- Limited assurance on selected non-core indicators
- No limitations to assurance scope
- All BRSR Core indicators found complete, accurate, and reliable